Healthequity Inc Stock Price, News & Analysis

HealthEquity reported Q1 FY23 revenue of $205.7 million, marking a 12% increase from $184.2 million in Q1 FY22. However, the company incurred a net loss of $13.6 million compared to $2.6 million in the previous year, with non-GAAP net income falling by 27% to $22.7 million. Adjusted EBITDA was $58.3 million, down 1%. The total number of HSAs increased by 26% to 7.4 million, with total HSA assets reaching $20.3 billion—a 35% increase. Outlook for FY23 projects revenues between $827 million and $837 million.

HealthEquity, the largest independent health savings account provider in the U.S., will announce its fiscal Q1 2023 financial results after market close on June 6, 2022. A conference call for investors will occur on the same day at 4:30 p.m. ET, allowing management to discuss the results. Additionally, HealthEquity will participate in the 2022 RW Baird Conference on June 7, 2022. For over 14 million accounts, HealthEquity partners with employers and advisors, focusing on enhancing consumer-directed benefits.

HealthEquity (NASDAQ: HQY) has released its second annual Corporate Social Responsibility (CSR) Report, highlighting advancements in ESG efforts and setting measurable goals for future improvement. The report emphasizes the company's commitment to transparency and includes a Materiality Assessment using recognized frameworks like the Global Reporting Initiative and Sustainability Accounting Standards Board. The company aims to enhance workforce diversity and create an inclusive environment, believing such efforts drive innovation and fulfill customer needs.

HealthEquity, Inc. (NASDAQ: HQY) announced the appointment of Rajesh (Nat) Natarajan to its Board of Directors, expanding the Board to 11 members, with 9 being independent. Natarajan brings over 25 years of experience in technology and product strategy, having held senior roles at notable companies like Globalization Partners and RingCentral. His expertise aligns with HealthEquity's growth objectives, focusing on innovation and enhancing product offerings. Chairman Robert Selander expressed confidence in Natarajan's ability to drive growth at HealthEquity, which serves over 14 million accounts.

HealthEquity reported FY22 revenue of $756.6 million, up 3% year-over-year, but incurred a net loss of $44.3 million compared to net income of $8.8 million in FY21. Non-GAAP net income was $110.2 million, down from $127.6 million. The company closed significant acquisitions and increased HSA accounts by 25%, totaling 7.2 million HSAs. The outlook for FY23 anticipates revenues of $820 million to $830 million, with expected net losses between $61 million and $53 million.

HealthEquity, Inc. (NASDAQ: HQY) announced it will report its fiscal year-end financial results on March 22, 2022, after market close. A conference call is scheduled for the same day at 4:30 PM ET, where management will discuss Q4 and fiscal year results ending January 31, 2022. The company also plans to present virtually at the KeyBank Virtual Life Sciences & Medtech Investor Forum on March 23, 2022. HealthEquity serves over 14 million accounts, focusing on connecting health and wealth.